BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
2861 – 2870 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Heparan sulfate proteoglycan-mediated polyamine uptake.
(
- Contribution to journal › Article
-
Mark
Towards optimised information about clinical trials; identification and validation of key issues in collaboration with cancer patient advocates.
(
- Contribution to journal › Article
-
Mark
SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas.
(
- Contribution to journal › Article
-
Mark
Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families.
(
- Contribution to journal › Article
-
Mark
Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities.
(
- Contribution to journal › Article
-
Mark
SMAD4 binds HOXA9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by HOXA9 and leukemia transformation.
(
- Contribution to journal › Article
-
Mark
C-KIT Signaling Depends on Microphthalmia-Associated Transcription Factor for Effects on Cell Proliferation.
(
- Contribution to journal › Article
-
Mark
CYLD: a deubiquitination enzyme with multiple roles in cancer.
(
- Contribution to journal › Article
-
Mark
MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid Sarcoma.
(
- Contribution to journal › Article
-
Mark
Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
(
- Contribution to journal › Article